249 related articles for article (PubMed ID: 7156891)
1. Pyridoxine-responsive primary acquired sideroblastic anaemia. In vitro and in vivo effects of vitamin B6 on decreased 5-aminolaevulinate synthase activity.
Meier PJ; Fehr J; Meyer UA
Scand J Haematol; 1982 Nov; 29(5):421-4. PubMed ID: 7156891
[TBL] [Abstract][Full Text] [Related]
2. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
[TBL] [Abstract][Full Text] [Related]
3. [Acquired, vitamin B6-responsive, primary sideroblastic anemia, an enzyme deficiency in heme synthesis].
Meier PJ; Giger U; Brändli O; Fehr J
Schweiz Med Wochenschr; 1981 Oct; 111(41):1533-5. PubMed ID: 7313623
[TBL] [Abstract][Full Text] [Related]
4. Haema synthesis during pyridoxine therapy in two families with different types of hereditary sideroblastic anaemia.
Pasanen AV; Salmi M; Tenhunen R; Vuopio P
Ann Clin Res; 1982 Apr; 14(2):61-5. PubMed ID: 7149613
[TBL] [Abstract][Full Text] [Related]
5. Multiple enzymatic defects in mitochondria in hematological cells of patients with primary sideroblastic anemia.
Aoki Y
J Clin Invest; 1980 Jul; 66(1):43-9. PubMed ID: 6249845
[TBL] [Abstract][Full Text] [Related]
6. Haem synthesis in sideroblastic anaemia.
Konopka L; Hoffbrand AV
Br J Haematol; 1979 May; 42(1):73-83. PubMed ID: 465361
[TBL] [Abstract][Full Text] [Related]
7. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia.
May A; Bishop DF
Haematologica; 1998 Jan; 83(1):56-70. PubMed ID: 9542324
[TBL] [Abstract][Full Text] [Related]
8. Sideroblastic anemia showing unique response to pyridoxine.
Murakami R; Takumi T; Gouji J; Nakamura H; Kondou M
Am J Pediatr Hematol Oncol; 1991; 13(3):345-50. PubMed ID: 1793162
[TBL] [Abstract][Full Text] [Related]
9. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease.
Aoki Y; Muranaka S; Nakabayashi K; Ueda Y
J Clin Invest; 1979 Nov; 64(5):1196-203. PubMed ID: 500806
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow delta-aminolaevulinate synthase deficiency in a female with congenital sideroblastic anemia.
Buchanan GR; Bottomley SS; Nitschke R
Blood; 1980 Jan; 55(1):109-15. PubMed ID: 7350930
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolaevulinic acid synthase activity in developing human erythroblasts.
Fitzsimons EJ; May A; Elder GH; Jacobs A
Br J Haematol; 1988 Jun; 69(2):281-5. PubMed ID: 3390396
[TBL] [Abstract][Full Text] [Related]
12. A study of a female with congenital sideroblastic anemia.
Manabe Y; Seto S; Furusho K; Aoki Y
Am J Hematol; 1982 Feb; 12(1):63-7. PubMed ID: 7039309
[TBL] [Abstract][Full Text] [Related]
13. Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts.
Baumann Kreuziger LM; Wolanskyj AP; Hanson CA; Steensma DP
Eur J Haematol; 2011 Jun; 86(6):512-6. PubMed ID: 21388451
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation of the erythroid-specific gamma-Aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia.
Harigae H; Furuyama K; Kudo K; Hayashi N; Yamamoto M; Sassa S; Sasaki T
Am J Hematol; 1999 Oct; 62(2):112-4. PubMed ID: 10577279
[TBL] [Abstract][Full Text] [Related]
15. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the understanding of inherited sideroblastic anaemia.
Camaschella C
Br J Haematol; 2008 Oct; 143(1):27-38. PubMed ID: 18637800
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of primary acquired sideroblastic anemia with pyridoxal-5-phosphate. Recent experience].
Hansen OP; Drivsholm A; Hardt F
Ugeskr Laeger; 1976 Nov; 138(48):3035-8. PubMed ID: 982656
[No Abstract] [Full Text] [Related]
18. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
19. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
20. Homocystinuria. Evidence for three distinct classes of cystathionine beta-synthase mutants in cultured fibroblasts.
Fowler B; Kraus J; Packman S; Rosenberg LE
J Clin Invest; 1978 Mar; 61(3):645-53. PubMed ID: 641146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
